��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
川寶(1595)
月營收
季盈餘
2025/10/01
34.55元 (川寶股價)
2025/10/01
21.10% (年增率)
90百萬元 (營收)
川寶(1595) 年度營收走勢圖
川寶(1595)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/10
90,107
245.85%
74,409
21.10%
594,275
-20.93%
114/09
26,054
-59.59%
127,794
-79.61%
504,168
-25.55%
114/08
64,469
228.35%
82,869
-22.20%
478,114
-12.97%
114/07
19,634
-74.36%
50,953
-61.47%
413,645
-11.33%
114/06
76,574
133.00%
39,249
95.10%
394,011
-5.18%
114/05
32,864
-56.71%
77,412
-57.55%
317,437
-15.64%
114/04
75,921
-9.77%
91,764
-17.26%
284,573
-4.79%
114/03
84,144
16.05%
67,174
25.26%
208,652
0.74%
114/02
72,509
39.44%
50,410
43.84%
124,508
-11.03%
114/01
51,999
-33.42%
89,536
-41.92%
51,999
-41.92%
113/12
78,101
-9.02%
63,442
23.11%
915,514
-34.97%
113/11
85,843
15.37%
65,872
30.32%
837,413
-37.73%
113/10
74,409
-41.77%
128,317
-42.01%
751,570
-41.21%
113/09
127,794
54.21%
149,944
-14.77%
677,161
-41.12%
113/08
82,869
62.64%
104,912
-21.01%
549,367
-45.07%
113/07
50,953
29.82%
84,113
-39.42%
466,498
-47.89%
113/06
39,249
-49.30%
168,987
-76.77%
415,545
-48.77%
113/05
77,412
-15.64%
163,152
-52.55%
376,296
-41.40%
113/04
91,764
36.61%
160,468
-42.81%
298,884
-37.61%
113/03
67,174
33.26%
86,304
-22.17%
207,120
-34.98%
113/02
50,410
-43.70%
122,082
-58.71%
139,946
-39.74%
113/01
89,536
41.13%
110,169
-18.73%
89,536
-18.73%
112/12
63,442
-3.69%
120,027
-47.14%
1,407,762
-21.60%
112/11
65,872
-48.66%
137,035
-51.93%
1,344,725
-19.75%
112/10
128,317
-14.42%
120,022
6.91%
1,278,448
-16.91%
112/09
149,944
42.92%
138,072
8.60%
1,150,131
-18.93%
112/08
104,912
24.73%
119,938
-12.53%
1,000,187
-21.89%
112/07
84,113
-50.23%
134,610
-37.51%
895,275
-22.86%
112/06
168,987
3.58%
171,587
-1.52%
811,162
-20.94%
112/05
163,152
1.67%
162,270
0.54%
642,175
-24.84%
112/04
160,468
85.93%
192,211
-16.51%
479,023
-30.79%
112/03
86,304
-29.31%
164,265
-47.46%
318,555
-36.28%
112/02
122,082
10.81%
158,941
-23.19%
232,251
-30.81%
112/01
110,169
-8.21%
176,745
-37.67%
110,169
-37.67%
111/12
120,027
-12.41%
198,038
-39.39%
1,795,723
-25.71%
111/11
137,035
14.17%
214,620
-36.15%
1,675,696
-24.48%
111/10
120,022
-13.07%
253,639
-52.68%
1,538,661
-23.23%
111/09
138,072
15.12%
1,418,639
111/08
119,938
-10.90%
1,280,567
111/07
134,610
-21.55%
1,160,629
111/06
171,587
5.74%
1,026,019
111/05
162,270
-15.58%
854,432
111/04
192,211
17.01%
692,162
111/03
164,265
3.35%
499,951
111/02
158,941
-10.07%
335,686
111/01
176,745
-10.75%
176,745
110/12
198,038
-7.73%
2,417,036
110/11
214,620
-15.38%
2,218,998
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
